NEW YORK (GenomeWeb News) – Enzo Biochem's shareholders have re-elected Barry Weiner and Bernard Kasten to continue serving on its board of directors for three-year terms, the company said in a filing with the US Securities and Exchange Commission this week.

Weiner is the company’s president, CFO, and principal accounting officer.


Lumora said this week that it has appointed Hayden Jeffreys to its board of directors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.